Continuous infusion of 5-fluorouracil in ovarian cancer patients refractory to cisplatin and carboplatin.
de Graeff
A
A
Department of Internal Medicine (Section of Oncology), University Hospital, Utrecht, The Netherlands.
van Hoef
M E
ME
Tjia
P
P
Heintz
A P
AP
Neijt
J P
JP
D000328:Adult; D016190:Carboplatin / Q000627:therapeutic use*; D002945:Cisplatin / Q000627:therapeutic use*; D004341:Drug Evaluation; D004351:Drug Resistance; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D015918:Infusion Pumps, Implantable; D007262:Infusions, Intravenous; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D016190:Carboplatin; D002945:Cisplatin; D005472:Fluorouracil